Interdict

Curated by Signal

Developer of a small molecule therapeutics platform to address undruggable targets

Overview

Developer of a small molecule therapeutics platform to address undruggable targets. The company's platform specializes in addressing historically undruggable targets in oncology, rare diseases, neurodegeneration and autoimmunity.

Key facts

Founded: 2022
Headquarters: San Francisco, United States
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Flower Bowl
Online pharmacy for cannabis medical and recreational products
Health TechnologyInkster, United States
Omage
Provider of care management platform for elderly patients
Health TechnologySeattle, United States
MedSetGo
Online platform that connects patients, caregivers, and healthcare providers to streamline the delivery of medical services
Health TechnologyFremont, United States

About Interdict

What does Interdict do?

Developer of a small molecule therapeutics platform to address undruggable targets.

Where is Interdict headquartered?

Interdict is headquartered in San Francisco, United States.

When was Interdict founded?

Interdict was founded in 2022.

Which sector is Interdict in?

Interdict operates in Health Technology.

Who are Interdict's competitors?

Companies similar to Interdict include Flower Bowl, Omage, and MedSetGo.